Efficacy and safety of repaglinide and metformin combined in type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Repaglinide (Primary) ; Gliclazide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 06 May 2009 Actual end date (Nov 2003) added as reported by ClinicalTrials.gov.
- 06 May 2009 Planned number of patients changed from 340 to 324 as reported by ClinicalTrials.gov.